BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2552499)

  • 1. Proton spectroscopic imaging (Dixon method) of the liver: clinical utility.
    Schertz LD; Lee JK; Heiken JP; Molina PL; Totty WG
    Radiology; 1989 Nov; 173(2):401-5. PubMed ID: 2552499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal hepatic lesions: comparative MR imaging at 0.5 and 1.5 T.
    Steinberg HV; Alarcon JJ; Bernardino ME
    Radiology; 1990 Jan; 174(1):153-6. PubMed ID: 2152980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of liver metastases at 1.5 T: similar contrast discrimination with T1- and T2-weighted pulse sequences.
    Saini S; Li W; Wallner B; Hahn PF; Edelman RR
    Radiology; 1991 Nov; 181(2):449-53. PubMed ID: 1924787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
    Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
    AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of the liver: breath-hold T1-weighted MP-GRE compared with conventional T2-weighted SE imaging--lesion detection, localization, and characterization.
    de Lange EE; Mugler JP; Bosworth JE; DeAngelis GA; Gay SB; Hurt NS; Berr SS; Rosenblatt JM; Merickel LW; Harris EK
    Radiology; 1994 Mar; 190(3):727-36. PubMed ID: 8115619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal nodular hyperplasia of the liver: MR findings in 35 proved cases.
    Lee MJ; Saini S; Hamm B; Taupitz M; Hahn PF; Seneterre E; Ferrucci JT
    AJR Am J Roentgenol; 1991 Feb; 156(2):317-20. PubMed ID: 1898806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.
    Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR
    Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatic metastases by proton spectroscopic imaging. Work in progress.
    Lee JK; Heiken JP; Dixon WT
    Radiology; 1985 Aug; 156(2):429-33. PubMed ID: 2989973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement.
    Chang SD; Thoeni RF
    AJR Am J Roentgenol; 2008 May; 190(5):1318-23. PubMed ID: 18430850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.
    Dromain C; de Baere T; Baudin E; Galline J; Ducreux M; Boige V; Duvillard P; Laplanche A; Caillet H; Lasser P; Schlumberger M; Sigal R
    AJR Am J Roentgenol; 2003 Jan; 180(1):121-8. PubMed ID: 12490490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatic metastases with MR imaging: spin-echo vs phase-contrast pulse sequences at 0.6 T.
    Rummeny E; Saini S; Stark DD; Weissleder R; Compton CC; Ferrucci JT
    AJR Am J Roentgenol; 1989 Dec; 153(6):1207-11. PubMed ID: 2683677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging.
    Heiken JP; Lee JK; Dixon WT
    Radiology; 1985 Dec; 157(3):707-10. PubMed ID: 2997837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
    Pui MH; Goh PS; Choo HF; Fok EC
    Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid MR imaging with suspended respiration: clinical application in the liver.
    Edelman RR; Hahn PF; Buxton R; Wittenberg J; Ferrucci JT; Saini S; Brady TJ
    Radiology; 1986 Oct; 161(1):125-31. PubMed ID: 3763854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastases in fatty liver: appearance on conventional spin-echo, fast-spin-echo, and echo-planar T2-weighted MR images.
    Kanematsu M; Hoshi H; Kunieda K; Nandate Y; Kato M; Yokoyama R
    Radiat Med; 1998; 16(3):175-7. PubMed ID: 9715995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial experiences with MR in liver tumors].
    Uhlenbrock D; Börsch G; Beyer HK; Schmidt G
    Rofo; 1985 Aug; 143(2):200-7. PubMed ID: 2992037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.